News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Astrogenetix and NASA Sign Agreement to Continue Developing Medicines in Space to Save Lives on Earth


2/8/2012 10:02:08 AM

AUSTIN, Texas, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Astrogenetix Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), has entered into a Space Act Agreement (SAA) with NASA, (National Aeronautics and Space Administration). This SAA commits to providing the critical resources needed to continue utilizing the International Space Station (ISS) and to further the development of important on-orbit microgravity vaccines and therapeutic drug experiments.

Read at GlobeNewswire

comments powered by Disqus
Astrogenetix
NASA
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES